Pave the road to successful commercialization of your radiopharmaceutical innovation with CARI – The CPDC & adMare Radiopharmaceutical Initiative

You’re cordially invited to a webinar

If you are an academic researcher or a biotech company looking to advance your radiopharmaceutical innovation toward commercialization, join CPDC and adMare on October 15th, 2020 to find out how we may be able help.

What is CARI?

CARI is a collaboration between The Centre for Probe Development and Commercialization (CPDC) and adMare BioInnovations (adMare) where we will bring respective resources together to advance an area of tremendous therapeutic and commercial potential in which Canada can gain considerable global competitive advantage: RADIOPHARMACEUTICALS. The objective of CARI, is for CPDC and adMare to seek out and uncover radiopharmaceutical opportunities arising from academic discoveries and early enterprises, establish rigorous drug development programs around selected opportunities, and drive the generation of proof-of-principle and other data supportive of the commercialization of new radiopharmaceutical assets.

Have more questions about CARI? Then you don’t want to miss this Webinar!

Click Here to Register 

For more information on CARI and/or to explore potential collaborative drug development opportunities, please visit  here